Market Research Logo

Global Markets for Implantable Biomaterials

Global Markets for Implantable Biomaterials

The global market for implantable biomaterials in 2013 was worth nearly $75.1 billion. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019. This will result in $79.1 billion in 2014 and $109.5 billion global market in 2019.

This report provides:

An overview of the global market for biomaterials used in medical applications.

Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

Segmentation of the biomaterials based on the materials from which they are made including metallic, ceramic, polymeric, natural and composite materials.

Segmentation based on therapeutic or application area including orthopaedic, cardiovascular, dental, immunology and infection, pulmonary/respiratory disease, plastic surgery, ophthalmology, oncology, neurology, and more.

Comprehensive profiles of leading companies in the industry.


SCOPE OF THE REPORT

This market research report focuses on the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion and analysis of the application of biomaterials and a review of new and developing technology platforms. This report also examines companies that are actively developing and marketing medical biomaterials around the world. Detailed tables and charts with sales forecasts and market share data are also included.

Products that are used as biomaterials can be segmented by the materials from which they are made; for example:

Metallic.
Ceramic.
Polymeric.
Natural.
Composites.

In addition to the segmentation by material type, medical biomaterials can also be examined by application/therapeutic area as follows:

Orthopedic.
Cardiovascular.
Dental.
Immunology and infection.
Pulmonary/respiratory disease.
Plastic surgery.
Urology/gynecology.
Endocrinology and metabolic diseases.
Ophthalmology.
Oncology.
Dermatology and wound care.
Gastroenterology.
Neurology.
Oto-Rhino-Laryngology (ORL).

The global market for medical biomaterials has been estimated at $48 billion in 2013, and is expected to more than double by 2019, reaching $102.5 billion. The growth represents a compound annual growth rate (CAGR) of by the end of the forecast period.

In 2013, the cardiovascular biomaterial segment represented the largest single market segment, accounting for 34.5% of the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to experience the highest growth in the coming years.

North America is the largest market for biomaterials and is expected to grow at CAGR of 5.2% from 2014 to 2019 due to an increase in the aging population. Due to rising awareness of biomaterial products in Asia, and increased partnerships and collaborations, the Asian market is expected to grow at a CAGR of 21.5% from 2014 to 2019.

CHAPTER 1 INTRODUCTION
INTRODUCTION
STUDY GOALS AND OBJECTIVES
SCOPE OF THE REPORT
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
SUMMARY TABLE GLOBAL REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS BY REGION, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
CHAPTER 3 OVERVIEW
CLASSIFICATION OF BIOMATERIALS USED IN MEDICINE
FIGURE 1 CLASSIFICATION OF BIOMATERIALS
NATURAL BIOMATERIALS
SYNTHETIC BIOMATERIALS
COMBINED BIOMATERIALS
SYNTHETIC BIOMATERIALS
POLYMER BIOMATERIALS
Synthetic Polymeric Materials
TABLE 1 FDA LIST OF THERMOPLASTIC, THERMOSET/ELASTOMER AND ABSORBABLE BIOMATERIALS
Synthetic Non-Biodegradable Polymers
TABLE 2 FDA LIST OF ADHESIVE AND FLUID BIOMATERIALS
Ultra-high-Molecular-Weight Polyethylene
Polyetheretherketone (PEEK)
Polymethyl Methacrylate
TABLE 3 BONE CEMENT COMPONENTS
Polyethylene Terephthalate
Polytetrafluoroethylene
Synthetic Biodegradable Polymers
Hydrogels
METALLIC BIOMATERIAL ALLOYS AND TECHNOLOGIES
Stainless Steel
TABLE 4 FDA GENERAL CLASSIFICATION OF METALLIC BIOMATERIALS
COMPENDIUM
Cobalt Chromium Alloys
Titanium and Titanium Alloys
Shape Memory Metal (Nickel-Titanium Alloy (NiTi)
New Alloys
Modifying Compatibility and Functionality through Surface Modification
Recent Advances in Material Technology for Orthopedic Surgery
Electrospinning Nanofibers
"Superfinishing" of Implant Surfaces Using Micro Machine Processing
Electrophoretic Deposition (EPD) of Hydroxyapatite or Bioactive Glass
C
Metallic Alloys and Technologies
CERAMIC BIOMATERIALS
TABLE 5 FDA GENERAL CLASSIFICATION OF CERAMIC AND COMPOSITE
CERAMIC BIOMATERIALS COMPENDIUM
Bioinert Ceramics
Bioactive Ceramics
Hydroxylapatite
Tricalcium Phosphate (TCP)
Ceramic on Ceramic Bearings
COMPOSITE BIOMATERIALS
TABLE 6 FDA GENERAL CLASSIFICATION OF COMPOSITE BIOMATERIALS
COMPENDIUM
BIOMATERIALS OF BIOLOGICAL ORIGIN
FIGURE 7 GLOBAL REVENUE SHARES OF ORTHOPEDICS BIOMATERIALS BY REGION, 2013 (%)
HISTORICAL DEVELOPMENT OF BIOMATERIALS
BIOMATERIALS MARKET EVOLUTION
FIGURE 2 CLASSIFICATION OF BIOMATERIALS
HISTORY AND DEVELOPMENT OF ABSORBABLE AND ERODIBLE WOUND
CLOSURE BIOMATERIALS
Sutures
FIGURE 3 MARKET DYNAMICS BY THERAPEUTIC AREA
Surgical Glues
HISTORY AND DEVELOPMENT OF ABSORBABLE AND ERODIBLE ORTHOPEDIC
BIOMATERIALS
RECENT DEVELOPMENTS AND TECHNOLOGICAL ADVANCES IN ABSORBABLE
AND ERODIBLE BIOMATERIALS
ABSORBABLE AND ERODIBLE WOUND CLOSURE BIOMATERIALS
Developments into Control of Absorption or Degradation Rates for Absorbable Sutures
Development of Second-Generation Fibrin Sealants
Research into and Development of Bioabsorbables for Reduction of Post-Operative Adhesions
ABSORBABLE AND ERODIBLE ORTHOPEDIC BIOMATERIALS
Continued R&D into Recombinant Human Osteogenic Protein-1 (rhOP-1)
ONGOING AND FUTURE DEVELOPMENTS IN BIOMATERIAL TECHNOLOGIES
DEVELOPMENTS IN FIBER-BASED TISSUE ENGINEERING TECHNOLOGIES (FBTE)
Electrospinning Nanofibers
Thermally Induced Phase Separation
3-D Fiber-Deposited Scaffolds for Tissue Engineering and Organ Printing
Self-Assembling Tissue Engineering Systems
"SUPERFINISHING" OF IMPLANT SURFACES USING MMP
ELECTROPHORETIC DEPOSITION OF HYDROXYAPATITE OR BIOACTIVE GLASS
METALLIC ALLOYS AND TECHNOLOGIES
STEM CELL TECHNOLOGIES AND NANOENGINEERED BIOMATERIALS
DEVELOPMENTS IN CERAMIC TECHNOLOGIES
DEVELOPMENTS IN SMART POLYMERS AS BIOMATERIALS
EXAMPLES OF PROPRIETARY BIOMATERIAL TECHNOLOGIES
Dyneema Purity Fiber
Small Intestinal Submucosa Technology
Biomaterial-Based Platform Technology
CHAPTER 4 GLOBAL IMPLANTABLE BIOMATERIALS MARKET
INTRODUCTION
MARKET REVENUE ANALYSIS
GLOBAL MARKET REVENUE ANALYSIS
TABLE 8 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
FIGURE 4 GLOBAL MARKET FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
Global Market Revenue Analysis by Region
FIGURE 5 GLOBAL REVENUES FOR IMPLANTABLE BIOMATERIALS BY REGION, 2014 (%)
Global Market Revenue Analysis by Market Segment
TABLE 9 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 6 GLOBAL REVENUES FOR IMPLANTABLE BIOMATERIALS BY INDIVIDUAL SEGMENT, 2013 ($ MILLIONS)
TABLE 10 GLOBAL REVENUE FORECAST FOR BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
FIGURE 7 GLOBAL REVENUE SHARES OF ORTHOPEDICS BIOMATERIALS BY REGION, 2013 (%)
FIGURE 8 GLOBAL REVENUES FOR CARDIOVASCULAR BIOMATERIALS BY REGION, 2013 (%)
TABLE 11 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 12 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 13 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($MILLIONS)
TABLE 14 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 15 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
CHAPTER 5 NORTH AMERICAN MARKET FOR IMPLANTABLE
BIOMATERIALS
REGULATORY AND LEGISLATIVE REQUIREMENTS
UNITED STATES
FDA Medical Device Regulations
Regulatory Approval Process for Biomaterials
Centers for Medicare & Medicaid Services
The 2010 Affordable Care Act
Private Insurance
Traditional Fee-for-Service Health Insurance Plans
Health Maintenance Organizations (HMOs)
Preferred Provider Organizations (PPOs)
FIGURE 9 PRIVATE HEALTH INSURANCE COVERAGE IN THE U.S. AMONG PERSONS UNDER AGE 65, 2007-2011 (MILLION/%)
TABLE 16 PERSONAL HEALTHCARE EXPENDITURES; AGGREGATE AND PER CAPITA AMOUNTS, PERCENT DISTRIBUTION AND ANNUAL PERCENTAGE CHANGE BY SOURCE OF FUNDS, 2006-2018 ($BILLIONS)
CANADA
MARKET DYNAMICS
MARKET DRIVERS
Aging Population Principal Driver of Biomaterials in the European Market
Advances in Surgical Techniques, Material Sciences, Multiple Design
Options and Manufacturing Processes Continue to Help Stimulate
Market Development
Potential Market Opportunities for Use of Antimicrobial Biomaterials in
the U.S.
Opportunities for Biomaterial Use in Drug Delivery Systems Using
Microneedles
MARKET RESTRAINTS
Cost Containment Issues Restrain Growth and Development of the Implant Industry
Concerns over Cost Issues Relating to Drug-Eluting Stents
Continuing Fears and Concerns over Late Stent Thrombosis Restrain
Development of North American Market
MARKET REVENUE ANALYSIS
NORTH AMERICAN MARKET REVENUE ANALYSIS
North American Market Revenue Analysis
TABLE 17 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
FIGURE 10 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
North American Market Revenue Analysis by Country
TABLE 18 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
North American Market Revenue Analysis by Market Segment
TABLE 19 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 11 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
TABLE 20 NORTH AMERICAN REVENUE FORECAST FOR ORTHOPEDICS AND CARDIOVASCULAR BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
TABLE 21 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 22 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 23 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 24 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 25 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
MARKET SHARE ANALYSIS
NORTH AMERICAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
TABLE 26 NORTH AMERICAN MARKET SHARE ANALYSIS OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
TABLE 27 NORTH AMERICAN MARKET SHARE ANALYSIS OF ORTHOPEDIC BIOMATERIALS BY COMPANY, 2013
TABLE 28 NORTH AMERICAN MARKET SHARE ANALYSIS OF CARDIOVASCULAR BIOMATERIALS BY COMPANY, 2013 ($MILLIONS/%)
CHAPTER 6 EUROPEAN MARKET FOR IMPLANTABLE BIOMATERIALS
REGULATORY AND LEGISLATIVE REQUIREMENTS
(GENERAL) MEDICAL DEVICE DIRECTIVE, MDD (93/42/EEC)
ACTIVE IMPLANTABLE MEDICAL DEVICE DIRECTIVE, AIMDD (90/383/EEC)
IN VITRO DIAGNOSTIC MEDICAL DEVICE DIRECTIVE, IVDMDD (98/79/EC)
PIP Breast Implants
MoM Hip Implants
PROPOSAL FOR CHANGES TO THE MEDICAL DEVICE DIRECTIVE, MDD (93/42/EEC)
THE RUSSIAN FEDERATION
MARKET DYNAMICS
MARKET DRIVERS
Technological Advances in Materials, Operative Procedures, Product
Design and Manufacturing Processes Help Stimulate Market
Development
Growth and Development of Biomaterials for Use in Ophthalmics
Growth and Development of Biomaterials for Use in Dentistry
MARKET RESTRAINTS
Influence and Impact of the National Joint Registries on the Joint
Replacement Market
Impact of the PIP Breast Implant Scandal on the European Breast Implant
Market
Increased Competitive Product Pricing and Mandatory Tendering
Regarded as a Major Market Restraint
MARKET REVENUE ANALYSIS
EUROPEAN MARKET REVENUE ANALYSIS
TABLE 29 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
FIGURE 12 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
European Market Revenue Analysis by Country
TABLE 30 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
TABLE 31 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (FRANCE AND GERMANY), THROUGH 2019 ($ MILLIONS)
TABLE 32 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (ITALY AND SPAIN), THROUGH 2019 ($ MILLIONS)
TABLE 33 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (UNITED KINGDOM AND BENELUX), THROUGH 2019 ($ MILLIONS)
European Market Revenue Analysis by Market Segment
TABLE 34 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 13 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
TABLE 35 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 36 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 37 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 38 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 39 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 40 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
MARKET SHARE ANALYSIS
EUROPEAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
TABLE 41 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
TABLE 42 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS BY COMPANY, 2013
TABLE 43 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
CHAPTER 7 ASIA-PACIFIC MARKET FOR IMPLANTABLE BIOMATERIALS
JAPAN
REGULATORY AND LEGISLATIVE REQUIREMENTS
TABLE 44 OVERVIEW OF PHARMACEUTICAL AFFAIRS LAW (PAL) AND JAPANESE MEDICAL DEVICES NOMENCLATURE (JMDN) CODES AND RELATED CODES ACCORDING TO THE EU MDD
Marketing Authorization System
TABLE 45 REIMBURSEMENT CATEGORIES IN JAPAN
CHINA
OVERVIEW OF THE HEALTHCARE SYSTEM
FIGURE 14 THE CHINESE HEALTHCARE SYSTEM
HEALTHCARE REFORMS
New Rural Co-operative Medical Care System
Urban Residents Healthcare Insurance Scheme
HEALTHCARE INSTITUTIONS
TABLE 46 NUMBER OF HEALTHCARE INSTITUTIONS, ACCORDING TO OWNERSHIP IN CHINA, 2010 (NUMBER)
HOSPITAL RESOURCES
TABLE 47 TOTAL NUMBER OF HOSPITALS IN CHINA BY RANKING, 2010
INDIA
OVERVIEW OF THE HEALTHCARE SYSTEM
National Level
State Level
Regional Level
District Level
Sub-divisional/Taluka Level
Community Level
Primary Health Centers Level
Sub Health Center (SHC) Level
TABLE 48 OVERVIEW OF HEALTHCARE IN INDIA
HOSPITAL RESOURCES
POPULATION STATISTICS
SOUTH KOREA
MARKET DYNAMICS
MARKET DRIVERS
Booming Economies in Emerging Markets
Westernized Lifestyle Increases Cardiovascular Problems in the Asia-Pacific Region
Initiatives to Improve Dental Care in India
Growth in the Indian Market
Growing Population
Affluent Consumers
Health Expenditure
Lifestyle-Related Disorders Drive Demand
Resilient to the Recession
MARKET RESTRAINTS
China
Increased Involvement of Local Medical Device Companies
Lack of Penetration to Rural Parts of China
Complex Legislative and Regulatory Rules
Distribution
Distribution is Very Fragmented
Chinese Distributors Are Difficult to Manage
Relationships Are Key to Distribution
Limited Capability to Successfully Develop the Market
India
Inadequacies of India's Healthcare Infrastructure
Widespread Lack of Health Insurance
Lack of Access to Healthcare Services
Japan
MARKET REVENUE ANALYSIS
ASIA-PACIFIC: MARKET REVENUE ANALYSIS
TABLE 49 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
FIGURE 15 ASIA-PACIFIC REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
Asia-Pacific: Market Revenue Analysis by Country
TABLE 50 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
TABLE 51 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (CHINA AND JAPAN), THROUGH 2019 ($ MILLIONS)
TABLE 52 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (INDIA AND SOUTH KOREA), THROUGH 2019 ($ MILLIONS)
Asia-Pacific: Market Revenue Analysis by Market Segment
TABLE 53 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 16 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY INDIVIDUAL SEGMENT, 2013 ($ MILLIONS)
TABLE 54 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 55 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 56 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 57 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 58 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 59 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
MARKET SHARE ANALYSIS
ASIA-PACIFIC MARKET SHARE ANALYSIS BY MARKET SEGMENT
TABLE 60 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013
TABLE 61 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
TABLE 62 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ BILLIONS/%)
CHAPTER 8 LATIN AMERICAN MARKET FOR IMPLANTABLE
BIOMATERIALS
BRAZIL
BACKGROUND
Regulatory and Legislative Requirements
Market Entry and Reimbursement of Medical Devices: Brazil
ARGENTINA
BACKGROUND
Government-Funded Public Health Sector
Social Health Insurance Sector
Private Sector
Regulatory and Legislative Requirements
MEXICO
BACKGROUND
Legislation and Regulations Governing Medical Devices in Mexico
Health Insurance Structure Mexico
MARKET DYNAMICS
MARKET DRIVERS
Market Growth Opportunities in Brazil
Growth in Private Healthcare and Private Insurance Plans
Expansion and Modernization of Top Private Hospitals
Largest and Fastest-Growing Medical Device Market in Latin America
Government Support to Boost Brazil's Healthcare Sector
Expansion of Healthcare Opportunities in Mexico
Introduction of Tax-Funded Universal Health Coverage throughout Latin America
Anticipated Increase in the Burden of Cardiovascular Disease in Central and Latin America
MARKET RESTRAINTS
Diverse Regulatory Environment Constrains Latin American Medical
Device Market
Challenges Associated with Local Business Practices and Cultural
Conditions in Brazil
Issues Associated with the Distribution of Medical Devices in Latin
America
Pricing Issues
MARKET REVENUE ANALYSIS
LATIN AMERICAN MARKET REVENUE ANALYSIS
TABLE 63 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
FIGURE 17 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2029 ($ MILLIONS)
Latin American Market Revenue Analysis by Country
TABLE 64 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
TABLE 65 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (ARGENTINA AND BRAZIL), THROUGH 2019 ($ MILLIONS)
TABLE 66 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (CHILE AND MEXICO), THROUGH 2019 ($MILLIONS)
Latin American Market Revenue Analysis by Market Segment
TABLE 67 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 18 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
TABLE 68 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 69 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 70 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 71 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 72 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 73 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
MARKET SHARE ANALYSIS
LATIN AMERICAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
TABLE 74 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
TABLE 75 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDIC APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
TABLE 76 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
CHAPTER 9 MIDDLE EASTERN/AFRICAN MARKET FOR IMPLANTABLE
BIOMATERIALS
INTRODUCTION
SOUTH AFRICA
REGIONAL REGULATIONS, LEGISLATION AND REIMBURSEMENT: MIDDLE EAST/AFRICA
SOUTH AFRICAN MEDICAL DEVICE REGULATORY REQUIREMENTS
HEALTH INSURANCE STRUCTURE: SOUTH AFRICA
REIMBURSEMENT OF MEDICAL DEVICES: SOUTH AFRICA
SAUDI ARABIA
PUBLIC HEALTHCARE SYSTEM
Primary Healthcare Services
Secondary and Tertiary Healthcare Services
FIGURE 19 STRUCTURE OF THE HEALTHCARE SECTOR IN SAUDI ARABIA, 2012
FIGURE 20 NUMBER OF HOSPITALS IN SAUDI ARABIA BY SUPPLIER, 2012
Private Healthcare Sector
Medical Device Regulatory Requirements: Saudi Arabia
Health Insurance Structure: Saudi Arabia
MARKET DYNAMICS
MARKET DRIVERS
Encouraging Signs that Africa's Medical Device Market is Growing
Substantial Financial Support for Healthcare in Saudi Arabia
South Africa's Political Stability and Improved Economic Outlook Help
Support Growth in Healthcare Market
Improved Financial Factors Help Introduction of Cardiac Catheterization
Procedures in African Countries
MARKET RESTRAINTS
Manual Compression will Remain Principal Method of Vascular Closure
in Africa
Relatively Poorly Regulated and Low Level of Training/Education of Interventional Cardiologists in Africa
Poor Distribution Structure and Networks in Africa
Medical Tourism to India for African Patient Requiring Angioplasty
Procedures
MARKET REVENUE ANALYSIS
MIDDLE/EAST AFRICAN MARKET REVENUE ANALYSIS
TABLE 77 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
FIGURE 21 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
Middle East/African Market Revenue Analysis by Country
TABLE 78 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
TABLE 79 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
Middle East/African Market Revenue Analysis by Market Segment
TABLE 80 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($MILLIONS)
TABLE 81 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($MILLIONS)
TABLE 82 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
TABLE 83 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 84 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
TABLE 85 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ( MILLIONS)
MARKET SHARE ANALYSIS
MIDDLE EAST/AFRICAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
TABLE 86 MIDDLE EAST/AFRICAN MARKET SHARE ANALYSIS OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013
TABLE 87 MIDDLE EAST/AFRICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDIC APPLICATIONS BY COMPANY, 2013
TABLE 88 MIDDLE EAST/AFRICA MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013
CHAPTER 10 COMPANY PROFILES
AAP IMPLANTATE AG
AESCULAP AG & CO AG A DIVISION OF B. BRAUN MESUNGEN AG
ALCON (NOVARTIS)
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BAUMER S.A.
BAUSCH & LOMB INC. (VALEANT PHARMACEUTICALS INTERNATIONAL INC.)
BERKELEY ADVANCED BIOMATERIALS INC.
BIOMET INC.
BIOTRONIK SE & CO. KG
BOSTON SCIENTIFIC CORP.
COLLAGEN MATRIX INC.
THE COOK GROUP
CORBION PURAC
CORDIS CORP. (JOHNSON & JOHNSON)
CORIN GROUP PLC
COVIDIEN LTD.
C.R. BARD INC.
DEPUY SYNTHES (JOHNSON & JOHNSON)
EDWARDS LIFESCIENCES CORP.
ETHICON INC. AND ETHICON ENDO-SURGERY INC. (JOHNSON & JOHNSON)
EXACTECH, INC.
FZIOMED INC.
INTEGRA LIFESCIENCES CORP.
INVIBIO BIOMATERIALS SOLUTIONS
KYOCERA MEDICAL CORP.
LIFECELL CORP.
MEDTRONIC
NOBEL BIOCARE
NOVABONE PRODUCTS
ORGANOGENESIS INC.
ROYAL DSM N.V.
SMITH & NEPHEW
SORIN GROUP
ST. JUDE MEDICAL
STRAUMANN
STRYKER INC.
TORNIER N.V.
TUTOGEN MEDICAL GMBH
VASCUTEK, A TERUMO CO.
W.L. GORE & ASSOCIATES INC.
WRIGHT MEDICAL GROUP, INC.
ZIMMER HOLDINGS INC.
CHAPTER 11 APPENDIX A: COMPANY CONTACT DETAILS
CHAPTER 12 APPENDIX B: ACRONYMS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report